Unlock instant, AI-driven research and patent intelligence for your innovation.

Hyaluronic acid vitamin e succinate polymer and its preparation and use

A technology of hyaluronic acid and succinate, which is applied in the field of polymers, can solve the problem that normal cells and tissues are not killed, and achieve the effect of improving tumor targeting, high encapsulation rate, and simple and easy preparation method

Active Publication Date: 2017-04-26
BEIJING UNIV OF CHINESE MEDICINE
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Vitamin E succinate is a derivative of natural vitamin E, which can inhibit the proliferation and differentiation of tumors, selectively induce tumor cell apoptosis, but has no killing ability to normal cells and tissues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hyaluronic acid vitamin e succinate polymer and its preparation and use
  • Hyaluronic acid vitamin e succinate polymer and its preparation and use
  • Hyaluronic acid vitamin e succinate polymer and its preparation and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0052] Example 1 The synthesis of ethylenediamine-vitamin E succinate (NH 2 -ED-VES)

[0053] Vitamin E succinate (VES, 0.53 g, 1 mol) was dissolved in 20 ml of dichloromethane (DCM) and placed in a 100 ml eggplant-shaped bottle. After being dissolved, add in 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI, 0.38g, 2mol) and 1-hydroxybenzotriazole (HoBt, 0.14 g, 1mol), and magnetically stirred for 1h under ice bath. Ethylenediamine (ED, 68 μl, 5 mol) was added, and reacted at 30° C. for 24 h under nitrogen protection.

[0054] Determination by NMR 1 HNMR hydrogen spectrum determines the structure (as shown below) of the compound in embodiment 1, selects solvent to be CDCl 3 , the result is as figure 1 . The chemical shift is 6.5ppm for the H in -NH-CO- in the amide bond, 2.5ppm and 3.5ppm for the ethyl-CH in ethylenediamine respectively 2 -CH 2 H in -, below 3.0ppm is a typical H peak in vitamin E succinate.

[0055]

Embodiment 2

[0056] Example 2 Synthesis of hyaluronic acid-ethylenediamine-vitamin E succinate (HA-ED-VES) (the degree of substitution of vitamin E succinate is 5%)

[0057] HA (140mg, -COOH, 0.36mM, M=7000) was dissolved in 5ml of anhydrous formamide, heated in a water bath at 50°C with magnetic stirring to dissolve, and cooled to room temperature. EDC (150 mg) and NHS (100 mg) were added, and magnetically stirred for 2 h in an ice bath. Then NH 2 - ED-VES (400 mg, 1.40 mM) was dissolved in dimethylformamide and slowly added dropwise to the HA mixture. The reaction was stirred at 60° C. for 24 h under a nitrogen atmosphere. The reaction mixture was dialyzed against distilled water for 2 days, filtered, and freeze-dried to obtain a white powder.

[0058] Determination by NMR 1 HNMR to determine the combination of compounds in Example 2, using DMSO-d 6 as the solvent, the result is as figure 2 Shown, chemical shift 0.8-1.0ppm is -CH in vitamin E succinate 3 peak, and the chemical sh...

Embodiment 3

[0059] Example 3 Synthesis of hyaluronic acid-ethylenediamine-vitamin E succinate (HA-ED-VES) (the degree of substitution of vitamin E succinate is 10%)

[0060] HA (140mg, -COOH, 0.36mM, M=7000) was dissolved in 5ml of anhydrous formamide, heated in a water bath at 50°C with magnetic stirring to dissolve, and cooled to room temperature. EDC (150 mg) and NHS (100 mg) were added, and magnetically stirred for 2 h in an ice bath. Then NH 2 - ED-VES (1.0 g, 3.50 mM) was dissolved in dimethylformamide and slowly added dropwise to the HA mixture. The reaction was stirred at 60° C. for 24 h under a nitrogen atmosphere. The reaction mixture was dialyzed against excess distilled water for 2 days, filtered, and freeze-dried to obtain a white powder.

[0061] Determination by NMR 1 HNMR to determine the combination of compounds in Example 3, using DMSO-d 6 As a solvent, chemical shift 0.8-1.0ppm is -CH in vitamin E succinate 3 peak, and the chemical shift 1.8-2.0ppm is NHCOCH in hy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
degree of substitutionaaaaaaaaaa
degree of substitutionaaaaaaaaaa
Login to View More

Abstract

The invention relates to a hyaluronic acid-vitamin E succinate polymer as well as preparation and application thereof. Particularly, the hyaluronic acid-vitamin E succinate polymer is obtained by connecting vitamin E succinate with main-chain hyaluronic acid through a double-amido bridge chain, and the hyaluronic acid-vitamin E succinate polymer has a structural formula I as shown in the specification. Vitamin E succinate has high safety, low critical micelle concentration and good biocompatibility. The hyaluronic acid-vitamin E succinate polymer is simple in preparation process and is suitable for large-scale production. In addition, the carrying materials can be self-assembled into a micelle in an aqueous medium, can be used as carriers of oral or intravenous indissolvable medicines, genomic medicines, protein medicines and have great market application prospect.

Description

technical field [0001] The invention relates to a polymer, in particular to a hyaluronic acid vitamin E succinate polymer and its preparation and application Background technique [0002] Tumor is a malignant disease that affects human health. In the past three decades, the incidence of cancer in the world has increased at a rate of 3-5% per year. The current treatment strategy for tumors is a combination of chemotherapy, surgical resection, radiotherapy and biological therapy. Among them, drug chemotherapy is the most widely used method to treat tumors, but due to the toxic and side effects of drugs, normal tissues are also seriously affected during the treatment. How to improve the selectivity of chemotherapy drugs to tumor tissues, reduce their distribution in normal tissues, reduce their toxic and side effects, and improve the bioavailability of drugs is the key to improving the efficacy of anti-tumor chemotherapy drugs. [0003] A variety of drug carriers have been de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08B37/08A61K47/36A61P35/00A61K31/704A61K9/107
Inventor 屠鹏飞王金铃马文转
Owner BEIJING UNIV OF CHINESE MEDICINE